GL1X · GenesisL1 explorer

MolNFT v1 · #125368 · protein

IL13 in complex with tralokinumab

5L6Y · Interleukin-13: “IL13 in complex with tralokinumab”. X-ray diffraction, 6 pockets (best druggability 0.62). MolNFT v1 #125368 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5L6Y
Type
protein
Length
538 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-13; Tralokinumab Fab digest vh; Tralokiumab Fab digest vl
UniProt
P35225
Pockets
6 · best druggability 0.62

Structure

x-ray diffraction · 3 distinct chains · 15% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
CInterleukin-13protein9455% helix, 6% strandP35225
HTralokinumab Fab digest vhprotein2326% helix, 47% strand—
LTralokiumab Fab digest vlprotein2128% helix, 49% strand—

Ligands and binding sites

  • FMT · Formic acid · additive · 15 copies · chains H, L, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12990.620.8049empty
2900.550.8518FMT
34100.550.7354FMT
4740.380.7818empty
5970.380.7621FMT

Interfaces

3 interfaces between chains.

  • H–L · 1852 Ų buried · 11 hydrogen bonds · protein-protein
  • C–L · 536 Ų buried · 8 hydrogen bonds · protein-protein
  • C–H · 221 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 5L6Y · il13 in complex with tralokinumab · the same entry in another collection · chain C against C, TM-score 1.00
  • P35225 · AlphaFold monomer V2.0 prediction for interleukin-13 (P35225) · a predicted model of the same protein · chain C against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.